Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib

NCT00667147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Weekly Abraxane and Daily Vandetanib
DRUG: Abraxane every three weeks and daily vandetanib

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]